Aihua Li
- Oncology top 2%
- Chemokine receptors and signaling 9
- Cytokine Signaling Pathways and Interactions 3
- Cancer Cells and Metastasis 3
- Immunology top 5%
- Immunotherapy and Immune Responses 3
- Immunology and Allergy top 5%
- Cancer Research top 5%
- Molecular Biology top 10%
- Yeasts and Rust Fungi Studies 3
- Angiogenesis and VEGF in Cancer 3
-
- Gastric Cancer Management and Outcomes 3
- Neonatal Respiratory Health Research 3
- Co-authors
- Michelle L. VarneyBhavana J. DavéRakesh K. SinghSeema DubeyMaurice GodfreyPeng SunXing DaiBoan Li
- Journals
- American Journal Of Pathology (3 papers)Scientific Reports (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Aihua Li
65 papers receiving 2.9k citations
Hit Papers
Peers
Comparison fields: 5 of 127
- Oncology 1.0k
- Immunology 735
- Immunology and Allergy 180
- Cancer Research 391
- Molecular Biology 1.2k
Countries citing papers authored by Aihua Li
This map shows the geographic impact of Aihua Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aihua Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aihua Li more than expected).
Fields of papers citing papers by Aihua Li
This network shows the impact of papers produced by Aihua Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aihua Li. The network helps show where Aihua Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Aihua Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 0 | |
| 4 | 2024 | 11 | |
| 5 | 2024 | 1 | |
| 6 | 2024 | 6 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 13 | |
| 9 | 2023 | 28 | |
| 10 | 2022 | 0 | |
| 11 | 2022 | 11 | |
| 12 | 2011 | 2 | |
| 13 | 2010 | 111 | |
| 14 | 2010 | 24 | |
| 15 | 2009 | 70 | |
| 16 | Small molecule antagonists for CXCR1 and CXCR2 inhibit human colon cancer metastasis by decreasing angiogenesis and enhancing apoptosis | 2007 | 2 |
| 17 | 2007 | 29 | |
| 18 | IL-8 Directly Enhanced Endothelial Cell Survival, Proliferation, and Matrix Metalloproteinases Production and Regulated Angiogenesisbreakdown → | 2003 | 1084 |
| 19 | 2002 | 25 | |
| 20 | 2001 | 5 |
About Aihua Li
Aihua Li is a scholar working on Oncology, Immunology and Allergy and Endocrine and Autonomic Systems, having authored 69 papers that have together received 2.9k indexed citations. Recurring topics across this work include Chemokine receptors and signaling (9 papers), Gastric Cancer Management and Outcomes (3 papers), Neonatal Respiratory Health Research (3 papers), Cytokine Signaling Pathways and Interactions (3 papers), Yeasts and Rust Fungi Studies (3 papers), Cancer Cells and Metastasis (3 papers), Immunotherapy and Immune Responses (3 papers) and Angiogenesis and VEGF in Cancer (3 papers). The work is most often cited by research in Oncology (1.0k citations), Immunology (735 citations) and Immunology and Allergy (180 citations). Aihua Li has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Michelle L. Varney, Bhavana J. Davé, Rakesh K. Singh, Seema Dubey, Rakesh K. Singh, Maurice Godfrey, Peng Sun, Xing Dai, Boan Li and Yuanyang Yuan. Their work appears in journals such as American Journal Of Pathology, Scientific Reports, Bioorganic & Medicinal Chemistry Letters, Pathology International and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.